Double – Blind , Randomized, Parallel, Placebo Controlled Study Examining the Effect of Cross- Linked Polyelectrolyte (CLP) in Heart Failure Patients with Chronic Kidney Disease
DATE – 2009 -2011
Name of the specialist – Hayrapetyan G.G.
Role – Principal Investigator
– International Multicenter double-blind placebo – controlled research (number of protocol CTST - 21)
Jointly participating Organization – Sorbent Therapeutics (www.sorbent.com/, Julie Iwashita, Inc. 710 Lakeway Drive, Suite 290 Sunnyvalley, Ca 94085 USA, USA)
Result – effectiveness of CLP during cardiac insufficiency with chronic renal insufficiency is proved
Publications – scientific article in European Journal of Heart Failure, 2014